IRIS
BERNASCONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.144
AS - Asia 7.096
EU - Europa 5.463
SA - Sud America 871
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 136
OC - Oceania 11
Totale 22.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.942
CN - Cina 3.805
SG - Singapore 1.501
UA - Ucraina 1.022
IE - Irlanda 982
HK - Hong Kong 726
BR - Brasile 666
DE - Germania 662
FI - Finlandia 604
IT - Italia 553
VN - Vietnam 481
SE - Svezia 441
RU - Federazione Russa 440
FR - Francia 329
GB - Regno Unito 237
BD - Bangladesh 107
IN - India 104
CA - Canada 101
AR - Argentina 75
IQ - Iraq 56
JP - Giappone 56
MX - Messico 56
ZA - Sudafrica 49
NL - Olanda 46
ID - Indonesia 36
PK - Pakistan 34
TR - Turchia 33
PL - Polonia 29
CO - Colombia 26
EC - Ecuador 26
ES - Italia 26
VE - Venezuela 26
SA - Arabia Saudita 24
PH - Filippine 22
MA - Marocco 21
BE - Belgio 18
PY - Paraguay 18
AT - Austria 16
TN - Tunisia 16
UZ - Uzbekistan 15
MY - Malesia 13
AU - Australia 11
CL - Cile 11
JO - Giordania 11
KE - Kenya 11
CR - Costa Rica 10
RO - Romania 10
AZ - Azerbaigian 9
PA - Panama 9
IR - Iran 8
BO - Bolivia 7
DZ - Algeria 7
HN - Honduras 7
IL - Israele 7
LT - Lituania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
PE - Perù 6
AL - Albania 5
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
KR - Corea 5
KZ - Kazakistan 5
AO - Angola 4
CZ - Repubblica Ceca 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
PS - Palestinian Territory 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BW - Botswana 3
GR - Grecia 3
KG - Kirghizistan 3
NP - Nepal 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
MZ - Mozambico 2
NO - Norvegia 2
PT - Portogallo 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
Totale 22.709
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.242
Chandler 1.073
Dublin 982
Nanjing 951
San Jose 916
Ashburn 742
Hong Kong 711
Singapore 687
Dallas 525
Boardman 436
Nanchang 413
Beijing 363
Council Bluffs 285
Shenyang 270
Princeton 261
Lawrence 260
Changsha 255
Hebei 254
Wilmington 228
Lauterbourg 221
Jiaxing 206
New York 189
Los Angeles 188
Medford 179
Ho Chi Minh City 153
Tianjin 153
Hangzhou 143
Hanoi 137
Milan 113
Buffalo 110
Ann Arbor 109
Redondo Beach 94
Helsinki 82
Moscow 79
São Paulo 58
Shanghai 57
Santa Clara 54
Tokyo 51
Woodbridge 51
Norwalk 48
Munich 45
Toronto 45
Orem 44
Verona 41
Frankfurt am Main 34
Seattle 34
Johannesburg 29
Turku 29
Des Moines 28
Jinan 28
Rome 28
Zhengzhou 28
Baghdad 25
Chicago 25
Da Nang 25
Houston 24
London 24
Montreal 24
Fairfield 23
Pavia 23
Warsaw 23
Brooklyn 22
Guangzhou 21
Kunming 21
San Francisco 21
Rio de Janeiro 20
Brussels 18
Denver 18
Haiphong 18
Ningbo 18
Mexico City 17
Belo Horizonte 16
Nuremberg 16
Atlanta 15
Tashkent 15
The Dalles 15
Amsterdam 14
Guayaquil 14
Washington 14
Chennai 13
Columbus 13
Curitiba 13
Falkenstein 13
Falls Church 12
Lanzhou 12
Phoenix 12
Taizhou 12
Biên Hòa 11
Dhaka 11
Stockholm 11
Amman 10
Fuzhou 10
New Delhi 10
Pune 10
Auburn Hills 9
Baku 9
Bologna 9
Lahore 9
Manchester 9
Nairobi 9
Totale 14.498
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 191
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 164
FISH vantaggi e svantaggi 159
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 152
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 148
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 147
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 147
Blast phase of essential thrombocythemia: A single center study. 145
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 145
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 142
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 140
Alcaloidi della vinca e dell'epipodofillotossina 139
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 136
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 134
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 133
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 130
Acute myeloid leukemia and diabetes insipidus: results in five patients 125
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 124
Etoposide : il citostatico della linea monocitica 123
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 123
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 121
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 120
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 120
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 119
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 119
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 118
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 117
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 117
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 117
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 116
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 114
ABL1 amplification in T-cell acute lymphoblastic leukemia. 114
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 113
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 110
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 110
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 110
Alterazioni citogenetiche nelle leucemie linfatiche croniche 109
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 108
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 108
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 106
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 105
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 105
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 104
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 104
Additional chromosomal abnormalities in Ph positive clone: adverse prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis. 104
Infusione di linfociti del donatore nella recidiva dopo tapianto di midollo osseo allogenico 103
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 103
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 103
Central nervous system relapse in acute promyelocytic leucemia 102
Growth factors in the therapy of myelodisplasia: biological aspects. 102
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 102
Evolving approaches with alpha interferon in chronic myelogenous leukemia 101
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 101
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 100
Role of the molecular staging and response in the management of follicular lymphoma patients 99
Impiego della citosina a basse dosi: risultati global 99
Valutazione prognostica dele sindromi mielodisplastiche 99
Alterazioni citogenetiche nelle leucemie acute 99
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 97
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 97
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 96
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 96
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report 96
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 96
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 95
Treatment of relapsed and refractory acute myloid leukemia in adults 95
Localizzazione di mieloma multiplo al mascellare superiore 95
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 95
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 94
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 94
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 94
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 94
Selezione delle cellule CD 34 positive. 94
FuseFISH: Robust detection of transcribed gene fusions in single cells 94
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 94
Autoimmunita’ nella malattia da trapianto contro l’ospite 93
Leucemia mielomonocitica cronica 93
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 92
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 92
Exercise intolerance at high altitude (5050 m): critical power and W'. 92
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 92
L’ibridazione in situ per documentare il chimerismo e l’origine della recidiva nel trapianto allogenico di midollo osseo 91
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 91
Controllo delle infezioni nelle leucemie acute 91
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 91
Molecularly targeted therapy in acute myeloid leukemia. 90
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 90
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 89
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia—analysis of 848 patients 89
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 89
Classificazione citogenetica delle LAM: impatto prognostico e terapeutico 88
Complicanze emorragiche e trombotiche nel paziente chirurgico 88
Immunochemotherapy with rituximab, vincristine and 5-days cyclophosphamide (R-CV) for heavily pretreated follicular lymphoma 88
Hematopoietic growth factors in bone marrow transplantation 87
Interferon-alfa plus low-dose cytosine arabinoside in advanced phase chronic myeologenus leukaemia patients. 87
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 87
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 87
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 87
Graft-versus-host disease post trasfusionale 87
Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study 86
Totale 10.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.001 0 7 37 15 26 64 19 82 61 23 156 511
2022/20233.159 362 203 7 259 394 367 0 219 1.188 25 83 52
2023/20241.126 102 213 30 108 112 396 8 65 11 33 13 35
2024/20252.895 47 322 76 98 81 59 159 252 629 74 230 868
2025/20266.881 446 504 807 811 697 335 1.346 240 585 634 303 173
2026/2027424 131 293 0 0 0 0 0 0 0 0 0 0
Totale 22.861